Company intelligence / Profile preview

Khaled Juffali Company

Jeddah, Makkah, Saudi Arabia

Ownership: Private
Development stage: Other

Overview

KJC is a diversified Saudi investment group with interests in multiple sectors, including healthcare, pharma, and biotech, primarily through its subsidiary Arabio, which is the first biopharmaceutical company in the GCC focused on human vaccines and plasma products, with commercial products licensed by Novartis and supplying the Saudi Ministry of Health. KJC also partners with international healthcare consultancies but is not a clinical-stage biotech/pharma company itself.

Therapeutic areas: HematologyInfectious DiseasesOther
Modalities: VaccinesPlasma productsBiopharmaceuticals
Industry: Investors

Partnerships

ICME Healthcare (international healthcare consultancy, joint venture for healthcare advisory in Saudi Arabia)ACDIMA (strategic shareholder in Arabio)Tamer Group (strategic shareholder in Arabio)ICD (strategic shareholder in Arabio)

Beyond the preview

Go deeper on Khaled Juffali Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Khaled Juffali Company.

Explore the full profile